Despite the visit of a delegation to Amsterdam on Thursday 22 February, the European Parliament remains concerned by the process of relocating the European Medicines Agency (EMA). Speaking to the press, the chair of the committee on the environment (ENVI) stressed the risk of delays in the construction of the new site. He also called for the Parliament to have its say in the process.
Readers may recall that on 20 November of last year, the member states decided to relocate the headquarters...